UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000030920
Receipt number R000035307
Scientific Title Evaluation of the effect of dexmedetomidine on the incidence of delirium in patients after cardiovascular surgery: A randomized placebo-controlled trial
Date of disclosure of the study information 2018/01/23
Last modified on 2022/01/24 12:52:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Evaluation of the effect of dexmedetomidine on the incidence of delirium in patients after cardiovascular surgery: A randomized placebo-controlled trial

Acronym

Evaluation of the effect of dexmedetomidine on the incidence of delirium

Scientific Title

Evaluation of the effect of dexmedetomidine on the incidence of delirium in patients after cardiovascular surgery: A randomized placebo-controlled trial

Scientific Title:Acronym

Evaluation of the effect of dexmedetomidine on the incidence of delirium

Region

Japan


Condition

Condition

Patients more than or equal to 65 years old, who undergo cardiovascular surgery for valvular or coronary artery diseases under cardiopulmonary bypass with cardiac arrest

Classification by specialty

Cardiovascular surgery

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate whether dexmedetomidine can reduce the incidence of delirium in patients undergoing cardiovascular surgery

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The incidence of delirium until 2 postoperative day

Key secondary outcomes

The incidence of delirium until 5 postoperative day
The rate of haloperidol or risperidone use for delirium
The duration of invasive mechanical ventilation
The rate and duration of noninvasive ventilation
The rate of intra-aortic balloon pumping or extracorporeal membrane oxygenation management
The rate of duration in which the targetted sedation level evaluated by Richmond agitation sedation scale was achieved
The dose of catecholamines used
The rate and volume of blood transfusion
The degree of pain evaluated by Numerical rating scale during ICU stay
Cognitive function evaluated by Mini mental state examination at 7 postoperative day
Duration of ICU stay




Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

NO

Institution consideration


Blocking

YES

Concealment

Numbered container method


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Medicine

Interventions/Control_1

Intervention:
Infusion of dexmedetomidine immediately after ICU admission until 2 postoperative day(0.1-0.15 microgram/kg/hr)

Interventions/Control_2

Control:
Infusion of normal saline immediately after ICU admission until 2 postoperative day

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

65 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients more than or equal to 65 years old, who undergo cardiovascular surgery for valvular diseases or coronary artery diseases under cardiopulmonary bypass with cardiac arrest

Key exclusion criteria

Patients diagnoses as schizophrenia or depression
Patients with liver cirrhosis
Patients under dialysis management
Patient with heart rate less than 50/min
Patients with severe dementia
Patient without communication ability

Target sample size

140


Research contact person

Name of lead principal investigator

1st name Hiroshi
Middle name
Last name Morisaki

Organization

Keio University School of Medicine

Division name

Department of Anesthesiology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-1211

Email

morisaki@z8.keio.jp


Public contact

Name of contact person

1st name Hiromasa
Middle name
Last name Nagata

Organization

Keio University School of Medicine

Division name

Department of Anesthesiology

Zip code

160-8582

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

TEL

03-3353-1211

Homepage URL


Email

ojikino2@a5.keio.jp


Sponsor or person

Institute

Department of Anesthesiology, Keio University School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Anesthesiology, Keio University School of Medicine

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Ethics committee of Keio University School of Medicine

Address

35 Shinanomachi, Shinjuku-ku, Tokyo, Japan

Tel

03-5363-3611

Email

med-rinri-jimu@adst.keio.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

慶應義塾大学病院(東京都)


Other administrative information

Date of disclosure of the study information

2018 Year 01 Month 23 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 01 Month 14 Day

Date of IRB

2018 Year 01 Month 23 Day

Anticipated trial start date

2019 Year 10 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2018 Year 01 Month 21 Day

Last modified on

2022 Year 01 Month 24 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035307


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name